Opportunity Information: Apply for CDC RFA GH15 1559
Apply for CDC RFA GH15 1559
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Blood Transfusion Services in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Oct 3, 2014 and posted on Oct 3, 2014.
- Applicants must submit their applications by Nov 20, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Servico Nacional de Sangue (SENASA) is the sole official government source in the Republic of Mozambique for providing blood services. It has also been the sole provider of blood transfusion services in the Republic of Mozambique since it was established. SENASA is an Agency of the Government of Mozambique (GOM) Ministry of Health. SENASA, the sole provider of blood transfusion services in the Republic of Mozambique, provides comprehensive blood transfusion services for the country. SENASA has its central office in the city of Maputo and has established centers in all 11 provinces of the country (including Maputo City). SENASA provides a full range of services, including recruitment and retention on non remunerated donors, screening of blood for transfusion transmissible infections, such as HIV, Hepatitis B and C and syphilis. SENASA is actively involved in training clinicians and nurses in the proper use of blood and blood products.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Strengthening Blood Transfusion Services in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)," was issued by the U.S. Centers for Disease Control and Prevention (CDC) as a discretionary cooperative agreement under the health funding activity category. The overall aim is to continue supporting Mozambique's Ministry of Health in strengthening the national blood transfusion service so it can reliably provide blood and blood products that are both safe and sufficient for the population. A central theme of the announcement is transition: it is designed to hand over and sustain the gains from roughly 10 years of PEPFAR investments in blood safety by shifting greater leadership and long-term ownership to the Government of Mozambique.
The FOA focuses on two practical, system-level objectives that are foundational for a functioning national blood program. Objective 1 is to increase blood collection through voluntary, non-remunerated blood donation in order to meet the country's blood needs. This emphasis reflects global best practice in transfusion safety, where voluntary non-paid donation systems are generally associated with a safer and more stable blood supply, and it highlights the operational work required to recruit, retain, and manage donors at scale across provinces. Objective 2 is to improve the quality of blood testing, specifically strengthening infectious disease screening (including HIV, hepatitis B, hepatitis C, and syphilis), as well as improving core laboratory services such as blood typing and cross-matching. Together, these objectives target both sides of transfusion safety: ensuring enough blood is available when patients need it, and ensuring that the blood provided is properly screened and matched to reduce transfusion-transmitted infections and clinical complications.
Eligibility for the award is highly specific and essentially restricted to Mozambique's national blood service. The Servico Nacional de Sangue (SENASA) is identified as the sole official government source for blood services in Mozambique and the only provider of blood transfusion services since its establishment. SENASA operates under the Government of Mozambique Ministry of Health, with a central office in Maputo and blood service centers established in all 11 provinces (including Maputo City). The announcement describes SENASA as providing comprehensive services across the transfusion chain, including donor recruitment and retention, screening of donated blood for transfusion-transmissible infections, and workforce development activities such as training clinicians and nurses in the appropriate clinical use of blood and blood products. In practice, this indicates the cooperative agreement is structured to directly bolster the existing national platform rather than create parallel systems, consistent with the stated goal of transition and sustainability.
In terms of award structure and scale, the CDC anticipated making one award under this FOA. The award ceiling was listed as $1,000,000, with no stated award floor, and the total estimated funding amount is shown as $0 in the source record, which often reflects how certain federal listings are recorded rather than necessarily indicating no funds would be obligated. The opportunity also required cost sharing or matching, meaning the recipient would be expected to contribute resources (financial or in-kind, depending on the specific terms) toward program implementation, a common mechanism used to reinforce local investment and support long-term continuation beyond external funding. The CFDA number associated with the opportunity is 93.067 (Global AIDS), aligning the activity with PEPFAR's broader HIV-related public health goals, especially given the role of safe transfusion services in preventing HIV transmission and supporting clinical care.
Key administrative details situate the FOA in late 2014. It was posted and created on October 3, 2014, with an original and current closing date of November 20, 2014, and an archive date of December 20, 2014. For technical difficulties accessing the announcement, CDC directed applicants to its Procurement and Grants Office Technical Information Management Section via pgotim@cdc.gov and a listed phone number. Overall, the grant opportunity is best understood as a targeted, transition-oriented investment in national blood system performance, concentrating on expanding voluntary non-remunerated donation and raising the quality and reliability of testing and compatibility procedures, implemented through Mozambique's established national blood service infrastructure.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled "Strengthening Blood Transfusion Services in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which U.S. agency issued this opportunity?
The opportunity was issued by the U.S. Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is being used?
This is a discretionary cooperative agreement under the health funding activity category.
What is the overall aim of the program?
The overall aim is to continue supporting Mozambique's Ministry of Health in strengthening the national blood transfusion service so it can reliably provide blood and blood products that are both safe and sufficient for the population.
What is the central theme of the announcement?
A central theme is transition: the opportunity is designed to hand over and sustain gains from roughly 10 years of PEPFAR investments in blood safety by shifting greater leadership and long-term ownership to the Government of Mozambique.
What are the two main objectives of the FOA?
The FOA focuses on two system-level objectives: (1) increasing blood collection through voluntary, non-remunerated blood donation to meet the country's blood needs, and (2) improving the quality of blood testing and core laboratory services (including infectious disease screening, blood typing, and cross-matching).
What does Objective 1 focus on?
Objective 1 focuses on increasing blood collection through voluntary, non-remunerated blood donation to meet Mozambique's blood needs, including the operational work required to recruit, retain, and manage donors at scale across provinces.
Why does the FOA emphasize voluntary, non-remunerated donation?
The announcement reflects global best practice in transfusion safety, where voluntary non-paid donation systems are generally associated with a safer and more stable blood supply.
What does Objective 2 focus on?
Objective 2 focuses on improving the quality of blood testing by strengthening infectious disease screening (including HIV, hepatitis B, hepatitis C, and syphilis) and improving core laboratory services such as blood typing and cross-matching.
Which infections are specifically mentioned for screening improvements?
The FOA specifically mentions strengthening screening for HIV, hepatitis B, hepatitis C, and syphilis.
How do the two objectives support transfusion safety?
Together, they address both sides of transfusion safety: ensuring enough blood is available when needed and ensuring blood is properly screened and matched to reduce transfusion-transmitted infections and clinical complications.
Who is eligible to apply?
Eligibility is highly specific and essentially restricted to Mozambique's national blood service, the Servico Nacional de Sangue (SENASA), identified as the sole official government source for blood services in Mozambique and the only provider of blood transfusion services since its establishment.
What is SENASA and how is it positioned within the Government of Mozambique?
SENASA operates under the Government of Mozambique Ministry of Health, with a central office in Maputo and blood service centers established in all 11 provinces (including Maputo City).
What kinds of activities does SENASA provide across the transfusion chain?
The announcement describes SENASA as providing comprehensive services including donor recruitment and retention, screening of donated blood for transfusion-transmissible infections, and workforce development activities such as training clinicians and nurses in appropriate clinical use of blood and blood products.
How many awards did CDC anticipate making under this FOA?
CDC anticipated making one award under this funding opportunity.
What is the maximum (ceiling) award amount?
The award ceiling was listed as $1,000,000.
Is there a minimum (floor) award amount stated?
No award floor was stated in the provided information.
Why does the source record show a total estimated funding amount of $0?
The information notes that a $0 total estimated funding amount in source records often reflects how certain federal listings are recorded rather than necessarily indicating that no funds would be obligated.
Does this opportunity require cost sharing or matching?
Yes. The opportunity required cost sharing or matching, meaning the recipient would be expected to contribute resources toward program implementation (financial or in-kind, depending on the specific terms).
What is the CFDA number associated with this opportunity?
The CFDA number associated with the opportunity is 93.067 (Global AIDS).
How does this opportunity align with PEPFAR and HIV-related goals?
It aligns with PEPFAR's broader HIV-related public health goals given the role of safe transfusion services in preventing HIV transmission and supporting clinical care.
When was the opportunity posted and when did it close?
It was posted and created on October 3, 2014. The original and current closing date was November 20, 2014.
When was the opportunity archived?
The archive date was December 20, 2014.
Who should be contacted for technical difficulties accessing the announcement?
For technical difficulties, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section via email at pgotim@cdc.gov and a listed phone number.
What does the FOA indicate about avoiding parallel systems?
By structuring eligibility around SENASA and emphasizing transition and sustainability, the opportunity is described as directly bolstering the existing national platform rather than creating parallel systems.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Regional Consortia for High Resolution Cryoelectron Microscopy (U24)
Previous opportunity: Technical Assistance to Support the Implementation and Evaluation of HIV/AIDS Prevention, Care, Treatment, and Support Activities for Mothers, Children, and Families under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1559
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1559) also looked into and applied for these:
| Funding Opportunity |
|---|
| Regional Consortia for High Resolution Cryoelectron Microscopy (U24) Apply for RFA GM 16 001 Funding Number: RFA GM 16 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ensuring Reliable and Equitable Access to PMTCT Services for Key Populations in the Republic of Mali under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1605 Funding Number: CDC RFA GH15 1605 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R01) Apply for PA 14 358 Funding Number: PA 14 358 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthen the Capacity of the Republic of Malis National Institute for Public Health Research (INRSP) to Implement Laboratory Based Activities and Research in Support of STI/HIV Prevention and Care Services under the Presidents Emergency Plan for AI Apply for CDC RFA GH15 1606 Funding Number: CDC RFA GH15 1606 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R21) Apply for PA 14 359 Funding Number: PA 14 359 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Support the Ministry of Health (MOH) to Scale up and Improve HIV/AIDS Prevention, Care, and Treatment Services in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1547 Funding Number: CDC RFA GH15 1547 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Zambia DISCOVER H Apply for 611 DRAFT PROGRAM DESCRIPTION 001 Funding Number: 611 DRAFT PROGRAM DESCRIPTION 001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $60,000,000 |
| R40 Maternal and Child Health Research Program (MCHR) Apply for HRSA 15 062 Funding Number: HRSA 15 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 Maternal and Child Health Research Program (SDAS) Apply for HRSA 15 077 Funding Number: HRSA 15 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Service Area Competition Apply for HRSA 15 014 Funding Number: HRSA 15 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Hepatitis C Cooperative Research Centers Immunity to HCV Infection (U19) Apply for RFA AI 14 045 Funding Number: RFA AI 14 045 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| System Level Health Services and Policy Research on Health Disparities (R01) Apply for RFA MD 15 001 Funding Number: RFA MD 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NIMHD Academic Research Enhancement Award Enhancing Health Disparities Research at Undergraduate Institutions (R15) Apply for RFA MD 15 002 Funding Number: RFA MD 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 003 Funding Number: RFA MD 15 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Zambia Ministry of Healths Capacity to Provide Leadership to the National HIV/AIDS Response through Coordination, Policy Development, Mentorship and Training under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1600 Funding Number: CDC RFA GH15 1600 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,125,000 |
| Innovations for Healthy Living Improving Minority Health and Eliminating Health Disparities (R43) Apply for RFA MD 15 004 Funding Number: RFA MD 15 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp) Apply for PA 15 005 Funding Number: PA 15 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Vascular Dysfunction in the Pathogenesis of Severe Malaria (R01) Apply for RFA HL 15 023 Funding Number: RFA HL 15 023 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| IMPROVED SERVICES FOR VULNERABLE POPULATIONS (ISVP) Apply for RFA 696 14 000002 Funding Number: RFA 696 14 000002 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $37,000,000 |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for RFA NS 14 013 Funding Number: RFA NS 14 013 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1559", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.